Global Progesterone Capsules Supply, Demand and Key Producers, 2026-2032
The global Progesterone Capsules market size is expected to reach $ 487 million by 2032, rising at a market growth of 5.3% CAGR during the forecast period (2026-2032).
Progesterone Capsules are oral solid dosage forms containing progesterone, widely used for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and selected hormone replacement therapy regimens. The dosage form has a long clinical history and well-established prescribing practices. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), gelatin or plant-based capsule shells, oil-based solvent systems such as vegetable oils or medium-chain triglycerides, antioxidants and stabilizers, as well as pharmaceutical blister packaging materials; overall material costs are relatively low, while formulation stability and oral bioavailability management represent the main technical considerations. Downstream customers mainly include OB-GYN hospitals, fertility clinics, general hospital outpatient departments, and retail prescription pharmacies, with additional use in peri-menopausal hormone therapy in certain markets. The global nameplate capacity for Progesterone Capsules in 2025 is estimated at approximately 0.98 billion capsules, with actual sales of around 0.86 billion capsules. Driven by a high share of generics and intense regional competition, the global average ex-factory price is estimated at USD 0.38 per capsule. Overall industry gross margin is estimated at approximately 46%.
The market is currently in a highly mature and intensely competitive stage, characterized by a multi-regional supply base and a large number of active manufacturers. Generic products dominate, making price and accessibility the primary competitive factors. Clinical use patterns are well established and widely distributed across routine OB-GYN care and reproductive medicine settings, with limited dependence on individual brands. In most markets, progesterone capsules are regarded as standard therapies, and purchasing and prescribing behaviors are increasingly rational, with market fluctuations driven more by policy and channel dynamics than by fundamental shifts in clinical demand.
Looking ahead, overall demand is expected to follow a moderate and stable trajectory rather than experiencing significant expansion. As assisted reproduction and women?s healthcare services become more standardized, oral progesterone will continue to play a role within established treatment pathways. However, in certain clinical scenarios that emphasize patient compliance or treatment optimization, its relative advantages are being challenged by alternative dosage forms. Regionally, improving access in emerging markets will remain a key source of support, while mature markets place greater emphasis on individualized treatment strategies and patient experience.
Key growth drivers include demographic changes, delayed childbearing trends, and rising awareness of women's health, all of which provide a degree of long-term resilience to underlying demand. At the same time, a well-developed API and formulation supply chain has lowered production and entry barriers, ensuring consistent product availability. From a healthcare system perspective, mature oral formulations continue to offer advantages in cost control and ease of use, reinforcing their role as baseline therapies.
Nevertheless, the market faces several constraints. Extensive genericization has intensified price competition, compressing margins and limiting incentives for further innovation. Clinically, alternative delivery methods demonstrate improved adherence or performance in specific treatment phases, gradually diverting part of the demand. In addition, changes in reimbursement policies, centralized procurement mechanisms, and tightening regulatory requirements impose periodic pressure on market performance across regions, resulting in a market environment characterized by stability accompanied by ongoing challenges.
This report studies the global Progesterone Capsules production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone Capsules and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone Capsules that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone Capsules total production and demand, 2021-2032, (K Units)
Global Progesterone Capsules total production value, 2021-2032, (USD Million)
Global Progesterone Capsules production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Progesterone Capsules consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Progesterone Capsules domestic production, consumption, key domestic manufacturers and share
Global Progesterone Capsules production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Progesterone Capsules production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Progesterone Capsules production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Progesterone Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Viatris, Teva Pharmaceutical Industries, Besins Healthcare, Organon, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla, Lupin, Zhejiang Xianju Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone Capsules market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone Capsules Market, By Region:
1. How big is the global Progesterone Capsules market?
2. What is the demand of the global Progesterone Capsules market?
3. What is the year over year growth of the global Progesterone Capsules market?
4. What is the production and production value of the global Progesterone Capsules market?
5. Who are the key producers in the global Progesterone Capsules market?
6. What are the growth factors driving the market demand?
Progesterone Capsules are oral solid dosage forms containing progesterone, widely used for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and selected hormone replacement therapy regimens. The dosage form has a long clinical history and well-established prescribing practices. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), gelatin or plant-based capsule shells, oil-based solvent systems such as vegetable oils or medium-chain triglycerides, antioxidants and stabilizers, as well as pharmaceutical blister packaging materials; overall material costs are relatively low, while formulation stability and oral bioavailability management represent the main technical considerations. Downstream customers mainly include OB-GYN hospitals, fertility clinics, general hospital outpatient departments, and retail prescription pharmacies, with additional use in peri-menopausal hormone therapy in certain markets. The global nameplate capacity for Progesterone Capsules in 2025 is estimated at approximately 0.98 billion capsules, with actual sales of around 0.86 billion capsules. Driven by a high share of generics and intense regional competition, the global average ex-factory price is estimated at USD 0.38 per capsule. Overall industry gross margin is estimated at approximately 46%.
The market is currently in a highly mature and intensely competitive stage, characterized by a multi-regional supply base and a large number of active manufacturers. Generic products dominate, making price and accessibility the primary competitive factors. Clinical use patterns are well established and widely distributed across routine OB-GYN care and reproductive medicine settings, with limited dependence on individual brands. In most markets, progesterone capsules are regarded as standard therapies, and purchasing and prescribing behaviors are increasingly rational, with market fluctuations driven more by policy and channel dynamics than by fundamental shifts in clinical demand.
Looking ahead, overall demand is expected to follow a moderate and stable trajectory rather than experiencing significant expansion. As assisted reproduction and women?s healthcare services become more standardized, oral progesterone will continue to play a role within established treatment pathways. However, in certain clinical scenarios that emphasize patient compliance or treatment optimization, its relative advantages are being challenged by alternative dosage forms. Regionally, improving access in emerging markets will remain a key source of support, while mature markets place greater emphasis on individualized treatment strategies and patient experience.
Key growth drivers include demographic changes, delayed childbearing trends, and rising awareness of women's health, all of which provide a degree of long-term resilience to underlying demand. At the same time, a well-developed API and formulation supply chain has lowered production and entry barriers, ensuring consistent product availability. From a healthcare system perspective, mature oral formulations continue to offer advantages in cost control and ease of use, reinforcing their role as baseline therapies.
Nevertheless, the market faces several constraints. Extensive genericization has intensified price competition, compressing margins and limiting incentives for further innovation. Clinically, alternative delivery methods demonstrate improved adherence or performance in specific treatment phases, gradually diverting part of the demand. In addition, changes in reimbursement policies, centralized procurement mechanisms, and tightening regulatory requirements impose periodic pressure on market performance across regions, resulting in a market environment characterized by stability accompanied by ongoing challenges.
This report studies the global Progesterone Capsules production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone Capsules and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone Capsules that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone Capsules total production and demand, 2021-2032, (K Units)
Global Progesterone Capsules total production value, 2021-2032, (USD Million)
Global Progesterone Capsules production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Progesterone Capsules consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Progesterone Capsules domestic production, consumption, key domestic manufacturers and share
Global Progesterone Capsules production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Progesterone Capsules production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Progesterone Capsules production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Progesterone Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Viatris, Teva Pharmaceutical Industries, Besins Healthcare, Organon, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla, Lupin, Zhejiang Xianju Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone Capsules market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone Capsules Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Originator Products
- Branded Generics
- 6 Capsules Per Bottle
- 12 Capsules Per Bottle
- 30 Capsules Per Bottle
- Others
- Luteal Phase Support in Assisted Reproductive Technology
- Treatment of Luteal Phase Deficiency
- Others
- Hospital
- Clinic
- Others
- AbbVie
- Viatris
- Teva Pharmaceutical Industries
- Besins Healthcare
- Organon
- Sun Pharmaceutical Industries
- Zydus Lifesciences
- Cipla
- Lupin
- Zhejiang Xianju Pharmaceutical
- Zhejiang Medicine
- Zhejiang Shenzhou Pharmaceutical
- Beijing Foyou Pharma
- Humanwell PuraCap Pharmaceuticals
1. How big is the global Progesterone Capsules market?
2. What is the demand of the global Progesterone Capsules market?
3. What is the year over year growth of the global Progesterone Capsules market?
4. What is the production and production value of the global Progesterone Capsules market?
5. Who are the key producers in the global Progesterone Capsules market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Progesterone Capsules Introduction
1.2 World Progesterone Capsules Supply & Forecast
1.2.1 World Progesterone Capsules Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone Capsules Production (2021-2032)
1.2.3 World Progesterone Capsules Pricing Trends (2021-2032)
1.3 World Progesterone Capsules Production by Region (Based on Production Site)
1.3.1 World Progesterone Capsules Production Value by Region (2021-2032)
1.3.2 World Progesterone Capsules Production by Region (2021-2032)
1.3.3 World Progesterone Capsules Average Price by Region (2021-2032)
1.3.4 North America Progesterone Capsules Production (2021-2032)
1.3.5 Europe Progesterone Capsules Production (2021-2032)
1.3.6 China Progesterone Capsules Production (2021-2032)
1.3.7 Japan Progesterone Capsules Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone Capsules Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone Capsules Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone Capsules Demand (2021-2032)
2.2 World Progesterone Capsules Consumption by Region
2.2.1 World Progesterone Capsules Consumption by Region (2021-2026)
2.2.2 World Progesterone Capsules Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone Capsules Consumption (2021-2032)
2.4 China Progesterone Capsules Consumption (2021-2032)
2.5 Europe Progesterone Capsules Consumption (2021-2032)
2.6 Japan Progesterone Capsules Consumption (2021-2032)
2.7 South Korea Progesterone Capsules Consumption (2021-2032)
2.8 ASEAN Progesterone Capsules Consumption (2021-2032)
2.9 India Progesterone Capsules Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone Capsules Production Value by Manufacturer (2021-2026)
3.2 World Progesterone Capsules Production by Manufacturer (2021-2026)
3.3 World Progesterone Capsules Average Price by Manufacturer (2021-2026)
3.4 Progesterone Capsules Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone Capsules Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone Capsules in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone Capsules in 2025
3.6 Progesterone Capsules Market: Overall Company Footprint Analysis
3.6.1 Progesterone Capsules Market: Region Footprint
3.6.2 Progesterone Capsules Market: Company Product Type Footprint
3.6.3 Progesterone Capsules Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone Capsules Production Value Comparison
4.1.1 United States VS China: Progesterone Capsules Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone Capsules Production Comparison
4.2.1 United States VS China: Progesterone Capsules Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone Capsules Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone Capsules Consumption Comparison
4.3.1 United States VS China: Progesterone Capsules Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone Capsules Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone Capsules Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone Capsules Production (2021-2026)
4.5 China Based Progesterone Capsules Manufacturers and Market Share
4.5.1 China Based Progesterone Capsules Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone Capsules Production (2021-2026)
4.6 Rest of World Based Progesterone Capsules Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone Capsules Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone Capsules Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone Capsules Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Originator Products
5.2.2 Branded Generics
5.3 Market Segment by Type
5.3.1 World Progesterone Capsules Production by Type (2021-2032)
5.3.2 World Progesterone Capsules Production Value by Type (2021-2032)
5.3.3 World Progesterone Capsules Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World Progesterone Capsules Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 6 Capsules Per Bottle
6.2.2 12 Capsules Per Bottle
6.2.3 30 Capsules Per Bottle
6.2.4 Others
6.3 Market Segment by Dosage
6.3.1 World Progesterone Capsules Production by Dosage (2021-2032)
6.3.2 World Progesterone Capsules Production Value by Dosage (2021-2032)
6.3.3 World Progesterone Capsules Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone Capsules Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone Capsules Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone Capsules Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone Capsules Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone Capsules Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone Capsules Production by Application (2021-2032)
8.3.2 World Progesterone Capsules Production Value by Application (2021-2032)
8.3.3 World Progesterone Capsules Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AbbVie
9.1.1 AbbVie Details
9.1.2 AbbVie Major Business
9.1.3 AbbVie Progesterone Capsules Product and Services
9.1.4 AbbVie Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AbbVie Recent Developments/Updates
9.1.6 AbbVie Competitive Strengths & Weaknesses
9.2 Viatris
9.2.1 Viatris Details
9.2.2 Viatris Major Business
9.2.3 Viatris Progesterone Capsules Product and Services
9.2.4 Viatris Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Viatris Recent Developments/Updates
9.2.6 Viatris Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries Progesterone Capsules Product and Services
9.3.4 Teva Pharmaceutical Industries Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Besins Healthcare
9.4.1 Besins Healthcare Details
9.4.2 Besins Healthcare Major Business
9.4.3 Besins Healthcare Progesterone Capsules Product and Services
9.4.4 Besins Healthcare Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Besins Healthcare Recent Developments/Updates
9.4.6 Besins Healthcare Competitive Strengths & Weaknesses
9.5 Organon
9.5.1 Organon Details
9.5.2 Organon Major Business
9.5.3 Organon Progesterone Capsules Product and Services
9.5.4 Organon Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Organon Recent Developments/Updates
9.5.6 Organon Competitive Strengths & Weaknesses
9.6 Sun Pharmaceutical Industries
9.6.1 Sun Pharmaceutical Industries Details
9.6.2 Sun Pharmaceutical Industries Major Business
9.6.3 Sun Pharmaceutical Industries Progesterone Capsules Product and Services
9.6.4 Sun Pharmaceutical Industries Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.6.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.7 Zydus Lifesciences
9.7.1 Zydus Lifesciences Details
9.7.2 Zydus Lifesciences Major Business
9.7.3 Zydus Lifesciences Progesterone Capsules Product and Services
9.7.4 Zydus Lifesciences Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zydus Lifesciences Recent Developments/Updates
9.7.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.8 Cipla
9.8.1 Cipla Details
9.8.2 Cipla Major Business
9.8.3 Cipla Progesterone Capsules Product and Services
9.8.4 Cipla Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Cipla Recent Developments/Updates
9.8.6 Cipla Competitive Strengths & Weaknesses
9.9 Lupin
9.9.1 Lupin Details
9.9.2 Lupin Major Business
9.9.3 Lupin Progesterone Capsules Product and Services
9.9.4 Lupin Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Lupin Recent Developments/Updates
9.9.6 Lupin Competitive Strengths & Weaknesses
9.10 Zhejiang Xianju Pharmaceutical
9.10.1 Zhejiang Xianju Pharmaceutical Details
9.10.2 Zhejiang Xianju Pharmaceutical Major Business
9.10.3 Zhejiang Xianju Pharmaceutical Progesterone Capsules Product and Services
9.10.4 Zhejiang Xianju Pharmaceutical Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.10.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.11 Zhejiang Medicine
9.11.1 Zhejiang Medicine Details
9.11.2 Zhejiang Medicine Major Business
9.11.3 Zhejiang Medicine Progesterone Capsules Product and Services
9.11.4 Zhejiang Medicine Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Zhejiang Medicine Recent Developments/Updates
9.11.6 Zhejiang Medicine Competitive Strengths & Weaknesses
9.12 Zhejiang Shenzhou Pharmaceutical
9.12.1 Zhejiang Shenzhou Pharmaceutical Details
9.12.2 Zhejiang Shenzhou Pharmaceutical Major Business
9.12.3 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product and Services
9.12.4 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
9.12.6 Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
9.13 Beijing Foyou Pharma
9.13.1 Beijing Foyou Pharma Details
9.13.2 Beijing Foyou Pharma Major Business
9.13.3 Beijing Foyou Pharma Progesterone Capsules Product and Services
9.13.4 Beijing Foyou Pharma Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Beijing Foyou Pharma Recent Developments/Updates
9.13.6 Beijing Foyou Pharma Competitive Strengths & Weaknesses
9.14 Humanwell PuraCap Pharmaceuticals
9.14.1 Humanwell PuraCap Pharmaceuticals Details
9.14.2 Humanwell PuraCap Pharmaceuticals Major Business
9.14.3 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product and Services
9.14.4 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Humanwell PuraCap Pharmaceuticals Recent Developments/Updates
9.14.6 Humanwell PuraCap Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone Capsules Industry Chain
10.2 Progesterone Capsules Upstream Analysis
10.2.1 Progesterone Capsules Core Raw Materials
10.2.2 Main Manufacturers of Progesterone Capsules Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone Capsules Production Mode
10.6 Progesterone Capsules Procurement Model
10.7 Progesterone Capsules Industry Sales Model and Sales Channels
10.7.1 Progesterone Capsules Sales Model
10.7.2 Progesterone Capsules Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Progesterone Capsules Introduction
1.2 World Progesterone Capsules Supply & Forecast
1.2.1 World Progesterone Capsules Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone Capsules Production (2021-2032)
1.2.3 World Progesterone Capsules Pricing Trends (2021-2032)
1.3 World Progesterone Capsules Production by Region (Based on Production Site)
1.3.1 World Progesterone Capsules Production Value by Region (2021-2032)
1.3.2 World Progesterone Capsules Production by Region (2021-2032)
1.3.3 World Progesterone Capsules Average Price by Region (2021-2032)
1.3.4 North America Progesterone Capsules Production (2021-2032)
1.3.5 Europe Progesterone Capsules Production (2021-2032)
1.3.6 China Progesterone Capsules Production (2021-2032)
1.3.7 Japan Progesterone Capsules Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone Capsules Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone Capsules Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone Capsules Demand (2021-2032)
2.2 World Progesterone Capsules Consumption by Region
2.2.1 World Progesterone Capsules Consumption by Region (2021-2026)
2.2.2 World Progesterone Capsules Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone Capsules Consumption (2021-2032)
2.4 China Progesterone Capsules Consumption (2021-2032)
2.5 Europe Progesterone Capsules Consumption (2021-2032)
2.6 Japan Progesterone Capsules Consumption (2021-2032)
2.7 South Korea Progesterone Capsules Consumption (2021-2032)
2.8 ASEAN Progesterone Capsules Consumption (2021-2032)
2.9 India Progesterone Capsules Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone Capsules Production Value by Manufacturer (2021-2026)
3.2 World Progesterone Capsules Production by Manufacturer (2021-2026)
3.3 World Progesterone Capsules Average Price by Manufacturer (2021-2026)
3.4 Progesterone Capsules Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone Capsules Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone Capsules in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone Capsules in 2025
3.6 Progesterone Capsules Market: Overall Company Footprint Analysis
3.6.1 Progesterone Capsules Market: Region Footprint
3.6.2 Progesterone Capsules Market: Company Product Type Footprint
3.6.3 Progesterone Capsules Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone Capsules Production Value Comparison
4.1.1 United States VS China: Progesterone Capsules Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone Capsules Production Comparison
4.2.1 United States VS China: Progesterone Capsules Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone Capsules Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone Capsules Consumption Comparison
4.3.1 United States VS China: Progesterone Capsules Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone Capsules Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone Capsules Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone Capsules Production (2021-2026)
4.5 China Based Progesterone Capsules Manufacturers and Market Share
4.5.1 China Based Progesterone Capsules Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone Capsules Production (2021-2026)
4.6 Rest of World Based Progesterone Capsules Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone Capsules Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone Capsules Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone Capsules Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone Capsules Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Originator Products
5.2.2 Branded Generics
5.3 Market Segment by Type
5.3.1 World Progesterone Capsules Production by Type (2021-2032)
5.3.2 World Progesterone Capsules Production Value by Type (2021-2032)
5.3.3 World Progesterone Capsules Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World Progesterone Capsules Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 6 Capsules Per Bottle
6.2.2 12 Capsules Per Bottle
6.2.3 30 Capsules Per Bottle
6.2.4 Others
6.3 Market Segment by Dosage
6.3.1 World Progesterone Capsules Production by Dosage (2021-2032)
6.3.2 World Progesterone Capsules Production Value by Dosage (2021-2032)
6.3.3 World Progesterone Capsules Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone Capsules Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone Capsules Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone Capsules Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone Capsules Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone Capsules Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone Capsules Production by Application (2021-2032)
8.3.2 World Progesterone Capsules Production Value by Application (2021-2032)
8.3.3 World Progesterone Capsules Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AbbVie
9.1.1 AbbVie Details
9.1.2 AbbVie Major Business
9.1.3 AbbVie Progesterone Capsules Product and Services
9.1.4 AbbVie Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AbbVie Recent Developments/Updates
9.1.6 AbbVie Competitive Strengths & Weaknesses
9.2 Viatris
9.2.1 Viatris Details
9.2.2 Viatris Major Business
9.2.3 Viatris Progesterone Capsules Product and Services
9.2.4 Viatris Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Viatris Recent Developments/Updates
9.2.6 Viatris Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries Progesterone Capsules Product and Services
9.3.4 Teva Pharmaceutical Industries Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Besins Healthcare
9.4.1 Besins Healthcare Details
9.4.2 Besins Healthcare Major Business
9.4.3 Besins Healthcare Progesterone Capsules Product and Services
9.4.4 Besins Healthcare Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Besins Healthcare Recent Developments/Updates
9.4.6 Besins Healthcare Competitive Strengths & Weaknesses
9.5 Organon
9.5.1 Organon Details
9.5.2 Organon Major Business
9.5.3 Organon Progesterone Capsules Product and Services
9.5.4 Organon Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Organon Recent Developments/Updates
9.5.6 Organon Competitive Strengths & Weaknesses
9.6 Sun Pharmaceutical Industries
9.6.1 Sun Pharmaceutical Industries Details
9.6.2 Sun Pharmaceutical Industries Major Business
9.6.3 Sun Pharmaceutical Industries Progesterone Capsules Product and Services
9.6.4 Sun Pharmaceutical Industries Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.6.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.7 Zydus Lifesciences
9.7.1 Zydus Lifesciences Details
9.7.2 Zydus Lifesciences Major Business
9.7.3 Zydus Lifesciences Progesterone Capsules Product and Services
9.7.4 Zydus Lifesciences Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zydus Lifesciences Recent Developments/Updates
9.7.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.8 Cipla
9.8.1 Cipla Details
9.8.2 Cipla Major Business
9.8.3 Cipla Progesterone Capsules Product and Services
9.8.4 Cipla Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Cipla Recent Developments/Updates
9.8.6 Cipla Competitive Strengths & Weaknesses
9.9 Lupin
9.9.1 Lupin Details
9.9.2 Lupin Major Business
9.9.3 Lupin Progesterone Capsules Product and Services
9.9.4 Lupin Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Lupin Recent Developments/Updates
9.9.6 Lupin Competitive Strengths & Weaknesses
9.10 Zhejiang Xianju Pharmaceutical
9.10.1 Zhejiang Xianju Pharmaceutical Details
9.10.2 Zhejiang Xianju Pharmaceutical Major Business
9.10.3 Zhejiang Xianju Pharmaceutical Progesterone Capsules Product and Services
9.10.4 Zhejiang Xianju Pharmaceutical Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.10.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.11 Zhejiang Medicine
9.11.1 Zhejiang Medicine Details
9.11.2 Zhejiang Medicine Major Business
9.11.3 Zhejiang Medicine Progesterone Capsules Product and Services
9.11.4 Zhejiang Medicine Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Zhejiang Medicine Recent Developments/Updates
9.11.6 Zhejiang Medicine Competitive Strengths & Weaknesses
9.12 Zhejiang Shenzhou Pharmaceutical
9.12.1 Zhejiang Shenzhou Pharmaceutical Details
9.12.2 Zhejiang Shenzhou Pharmaceutical Major Business
9.12.3 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product and Services
9.12.4 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
9.12.6 Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
9.13 Beijing Foyou Pharma
9.13.1 Beijing Foyou Pharma Details
9.13.2 Beijing Foyou Pharma Major Business
9.13.3 Beijing Foyou Pharma Progesterone Capsules Product and Services
9.13.4 Beijing Foyou Pharma Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Beijing Foyou Pharma Recent Developments/Updates
9.13.6 Beijing Foyou Pharma Competitive Strengths & Weaknesses
9.14 Humanwell PuraCap Pharmaceuticals
9.14.1 Humanwell PuraCap Pharmaceuticals Details
9.14.2 Humanwell PuraCap Pharmaceuticals Major Business
9.14.3 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product and Services
9.14.4 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Humanwell PuraCap Pharmaceuticals Recent Developments/Updates
9.14.6 Humanwell PuraCap Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone Capsules Industry Chain
10.2 Progesterone Capsules Upstream Analysis
10.2.1 Progesterone Capsules Core Raw Materials
10.2.2 Main Manufacturers of Progesterone Capsules Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone Capsules Production Mode
10.6 Progesterone Capsules Procurement Model
10.7 Progesterone Capsules Industry Sales Model and Sales Channels
10.7.1 Progesterone Capsules Sales Model
10.7.2 Progesterone Capsules Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Progesterone Capsules Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone Capsules Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone Capsules Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone Capsules Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone Capsules Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone Capsules Production by Region (2021-2026) & (K Units)
Table 7. World Progesterone Capsules Production by Region (2027-2032) & (K Units)
Table 8. World Progesterone Capsules Production Market Share by Region (2021-2026)
Table 9. World Progesterone Capsules Production Market Share by Region (2027-2032)
Table 10. World Progesterone Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Progesterone Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Progesterone Capsules Major Market Trends
Table 13. World Progesterone Capsules Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Progesterone Capsules Consumption by Region (2021-2026) & (K Units)
Table 15. World Progesterone Capsules Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Progesterone Capsules Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone Capsules Producers in 2025
Table 18. World Progesterone Capsules Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Progesterone Capsules Producers in 2025
Table 20. World Progesterone Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Progesterone Capsules Company Evaluation Quadrant
Table 22. World Progesterone Capsules Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone Capsules Production Site of Key Manufacturer
Table 24. Progesterone Capsules Market: Company Product Type Footprint
Table 25. Progesterone Capsules Market: Company Product Application Footprint
Table 26. Progesterone Capsules Competitive Factors
Table 27. Progesterone Capsules New Entrant and Capacity Expansion Plans
Table 28. Progesterone Capsules Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone Capsules Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone Capsules Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Progesterone Capsules Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Progesterone Capsules Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone Capsules Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 37. China Based Progesterone Capsules Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone Capsules Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone Capsules Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone Capsules Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 47. World Progesterone Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone Capsules Production by Type (2021-2026) & (K Units)
Table 49. World Progesterone Capsules Production by Type (2027-2032) & (K Units)
Table 50. World Progesterone Capsules Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone Capsules Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Progesterone Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Progesterone Capsules Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone Capsules Production by Dosage (2021-2026) & (K Units)
Table 56. World Progesterone Capsules Production by Dosage (2027-2032) & (K Units)
Table 57. World Progesterone Capsules Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World Progesterone Capsules Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World Progesterone Capsules Average Price by Dosage (2021-2026) & (US$/Unit)
Table 60. World Progesterone Capsules Average Price by Dosage (2027-2032) & (US$/Unit)
Table 61. World Progesterone Capsules Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone Capsules Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Progesterone Capsules Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Progesterone Capsules Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone Capsules Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone Capsules Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Progesterone Capsules Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Progesterone Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone Capsules Production by Application (2021-2026) & (K Units)
Table 70. World Progesterone Capsules Production by Application (2027-2032) & (K Units)
Table 71. World Progesterone Capsules Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone Capsules Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Progesterone Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AbbVie Basic Information, Manufacturing Base and Competitors
Table 76. AbbVie Major Business
Table 77. AbbVie Progesterone Capsules Product and Services
Table 78. AbbVie Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AbbVie Recent Developments/Updates
Table 80. AbbVie Competitive Strengths & Weaknesses
Table 81. Viatris Basic Information, Manufacturing Base and Competitors
Table 82. Viatris Major Business
Table 83. Viatris Progesterone Capsules Product and Services
Table 84. Viatris Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Viatris Recent Developments/Updates
Table 86. Viatris Competitive Strengths & Weaknesses
Table 87. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 88. Teva Pharmaceutical Industries Major Business
Table 89. Teva Pharmaceutical Industries Progesterone Capsules Product and Services
Table 90. Teva Pharmaceutical Industries Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teva Pharmaceutical Industries Recent Developments/Updates
Table 92. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 93. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 94. Besins Healthcare Major Business
Table 95. Besins Healthcare Progesterone Capsules Product and Services
Table 96. Besins Healthcare Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Besins Healthcare Recent Developments/Updates
Table 98. Besins Healthcare Competitive Strengths & Weaknesses
Table 99. Organon Basic Information, Manufacturing Base and Competitors
Table 100. Organon Major Business
Table 101. Organon Progesterone Capsules Product and Services
Table 102. Organon Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Organon Recent Developments/Updates
Table 104. Organon Competitive Strengths & Weaknesses
Table 105. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 106. Sun Pharmaceutical Industries Major Business
Table 107. Sun Pharmaceutical Industries Progesterone Capsules Product and Services
Table 108. Sun Pharmaceutical Industries Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sun Pharmaceutical Industries Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 111. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 112. Zydus Lifesciences Major Business
Table 113. Zydus Lifesciences Progesterone Capsules Product and Services
Table 114. Zydus Lifesciences Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zydus Lifesciences Recent Developments/Updates
Table 116. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 117. Cipla Basic Information, Manufacturing Base and Competitors
Table 118. Cipla Major Business
Table 119. Cipla Progesterone Capsules Product and Services
Table 120. Cipla Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Cipla Recent Developments/Updates
Table 122. Cipla Competitive Strengths & Weaknesses
Table 123. Lupin Basic Information, Manufacturing Base and Competitors
Table 124. Lupin Major Business
Table 125. Lupin Progesterone Capsules Product and Services
Table 126. Lupin Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Lupin Recent Developments/Updates
Table 128. Lupin Competitive Strengths & Weaknesses
Table 129. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Zhejiang Xianju Pharmaceutical Major Business
Table 131. Zhejiang Xianju Pharmaceutical Progesterone Capsules Product and Services
Table 132. Zhejiang Xianju Pharmaceutical Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 134. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 136. Zhejiang Medicine Major Business
Table 137. Zhejiang Medicine Progesterone Capsules Product and Services
Table 138. Zhejiang Medicine Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Zhejiang Medicine Recent Developments/Updates
Table 140. Zhejiang Medicine Competitive Strengths & Weaknesses
Table 141. Zhejiang Shenzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Zhejiang Shenzhou Pharmaceutical Major Business
Table 143. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product and Services
Table 144. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
Table 146. Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Beijing Foyou Pharma Basic Information, Manufacturing Base and Competitors
Table 148. Beijing Foyou Pharma Major Business
Table 149. Beijing Foyou Pharma Progesterone Capsules Product and Services
Table 150. Beijing Foyou Pharma Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Beijing Foyou Pharma Recent Developments/Updates
Table 152. Beijing Foyou Pharma Competitive Strengths & Weaknesses
Table 153. Humanwell PuraCap Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 154. Humanwell PuraCap Pharmaceuticals Major Business
Table 155. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product and Services
Table 156. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Humanwell PuraCap Pharmaceuticals Recent Developments/Updates
Table 158. Humanwell PuraCap Pharmaceuticals Competitive Strengths & Weaknesses
Table 159. Global Key Players of Progesterone Capsules Upstream (Raw Materials)
Table 160. Global Progesterone Capsules Typical Customers
Table 161. Progesterone Capsules Typical Distributors
Table 1. World Progesterone Capsules Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone Capsules Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone Capsules Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone Capsules Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone Capsules Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone Capsules Production by Region (2021-2026) & (K Units)
Table 7. World Progesterone Capsules Production by Region (2027-2032) & (K Units)
Table 8. World Progesterone Capsules Production Market Share by Region (2021-2026)
Table 9. World Progesterone Capsules Production Market Share by Region (2027-2032)
Table 10. World Progesterone Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Progesterone Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Progesterone Capsules Major Market Trends
Table 13. World Progesterone Capsules Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Progesterone Capsules Consumption by Region (2021-2026) & (K Units)
Table 15. World Progesterone Capsules Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Progesterone Capsules Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone Capsules Producers in 2025
Table 18. World Progesterone Capsules Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Progesterone Capsules Producers in 2025
Table 20. World Progesterone Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Progesterone Capsules Company Evaluation Quadrant
Table 22. World Progesterone Capsules Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone Capsules Production Site of Key Manufacturer
Table 24. Progesterone Capsules Market: Company Product Type Footprint
Table 25. Progesterone Capsules Market: Company Product Application Footprint
Table 26. Progesterone Capsules Competitive Factors
Table 27. Progesterone Capsules New Entrant and Capacity Expansion Plans
Table 28. Progesterone Capsules Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone Capsules Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone Capsules Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Progesterone Capsules Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Progesterone Capsules Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone Capsules Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 37. China Based Progesterone Capsules Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone Capsules Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone Capsules Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone Capsules Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone Capsules Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone Capsules Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Progesterone Capsules Production Market Share (2021-2026)
Table 47. World Progesterone Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone Capsules Production by Type (2021-2026) & (K Units)
Table 49. World Progesterone Capsules Production by Type (2027-2032) & (K Units)
Table 50. World Progesterone Capsules Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone Capsules Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Progesterone Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Progesterone Capsules Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone Capsules Production by Dosage (2021-2026) & (K Units)
Table 56. World Progesterone Capsules Production by Dosage (2027-2032) & (K Units)
Table 57. World Progesterone Capsules Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World Progesterone Capsules Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World Progesterone Capsules Average Price by Dosage (2021-2026) & (US$/Unit)
Table 60. World Progesterone Capsules Average Price by Dosage (2027-2032) & (US$/Unit)
Table 61. World Progesterone Capsules Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone Capsules Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Progesterone Capsules Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Progesterone Capsules Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone Capsules Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone Capsules Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Progesterone Capsules Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Progesterone Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone Capsules Production by Application (2021-2026) & (K Units)
Table 70. World Progesterone Capsules Production by Application (2027-2032) & (K Units)
Table 71. World Progesterone Capsules Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone Capsules Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Progesterone Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AbbVie Basic Information, Manufacturing Base and Competitors
Table 76. AbbVie Major Business
Table 77. AbbVie Progesterone Capsules Product and Services
Table 78. AbbVie Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AbbVie Recent Developments/Updates
Table 80. AbbVie Competitive Strengths & Weaknesses
Table 81. Viatris Basic Information, Manufacturing Base and Competitors
Table 82. Viatris Major Business
Table 83. Viatris Progesterone Capsules Product and Services
Table 84. Viatris Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Viatris Recent Developments/Updates
Table 86. Viatris Competitive Strengths & Weaknesses
Table 87. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 88. Teva Pharmaceutical Industries Major Business
Table 89. Teva Pharmaceutical Industries Progesterone Capsules Product and Services
Table 90. Teva Pharmaceutical Industries Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teva Pharmaceutical Industries Recent Developments/Updates
Table 92. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 93. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 94. Besins Healthcare Major Business
Table 95. Besins Healthcare Progesterone Capsules Product and Services
Table 96. Besins Healthcare Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Besins Healthcare Recent Developments/Updates
Table 98. Besins Healthcare Competitive Strengths & Weaknesses
Table 99. Organon Basic Information, Manufacturing Base and Competitors
Table 100. Organon Major Business
Table 101. Organon Progesterone Capsules Product and Services
Table 102. Organon Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Organon Recent Developments/Updates
Table 104. Organon Competitive Strengths & Weaknesses
Table 105. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 106. Sun Pharmaceutical Industries Major Business
Table 107. Sun Pharmaceutical Industries Progesterone Capsules Product and Services
Table 108. Sun Pharmaceutical Industries Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sun Pharmaceutical Industries Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 111. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 112. Zydus Lifesciences Major Business
Table 113. Zydus Lifesciences Progesterone Capsules Product and Services
Table 114. Zydus Lifesciences Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zydus Lifesciences Recent Developments/Updates
Table 116. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 117. Cipla Basic Information, Manufacturing Base and Competitors
Table 118. Cipla Major Business
Table 119. Cipla Progesterone Capsules Product and Services
Table 120. Cipla Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Cipla Recent Developments/Updates
Table 122. Cipla Competitive Strengths & Weaknesses
Table 123. Lupin Basic Information, Manufacturing Base and Competitors
Table 124. Lupin Major Business
Table 125. Lupin Progesterone Capsules Product and Services
Table 126. Lupin Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Lupin Recent Developments/Updates
Table 128. Lupin Competitive Strengths & Weaknesses
Table 129. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Zhejiang Xianju Pharmaceutical Major Business
Table 131. Zhejiang Xianju Pharmaceutical Progesterone Capsules Product and Services
Table 132. Zhejiang Xianju Pharmaceutical Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 134. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 136. Zhejiang Medicine Major Business
Table 137. Zhejiang Medicine Progesterone Capsules Product and Services
Table 138. Zhejiang Medicine Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Zhejiang Medicine Recent Developments/Updates
Table 140. Zhejiang Medicine Competitive Strengths & Weaknesses
Table 141. Zhejiang Shenzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Zhejiang Shenzhou Pharmaceutical Major Business
Table 143. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product and Services
Table 144. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
Table 146. Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Beijing Foyou Pharma Basic Information, Manufacturing Base and Competitors
Table 148. Beijing Foyou Pharma Major Business
Table 149. Beijing Foyou Pharma Progesterone Capsules Product and Services
Table 150. Beijing Foyou Pharma Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Beijing Foyou Pharma Recent Developments/Updates
Table 152. Beijing Foyou Pharma Competitive Strengths & Weaknesses
Table 153. Humanwell PuraCap Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 154. Humanwell PuraCap Pharmaceuticals Major Business
Table 155. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product and Services
Table 156. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Humanwell PuraCap Pharmaceuticals Recent Developments/Updates
Table 158. Humanwell PuraCap Pharmaceuticals Competitive Strengths & Weaknesses
Table 159. Global Key Players of Progesterone Capsules Upstream (Raw Materials)
Table 160. Global Progesterone Capsules Typical Customers
Table 161. Progesterone Capsules Typical Distributors
LIST OF FIGURES
Figure 1. Progesterone Capsules Picture
Figure 2. World Progesterone Capsules Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone Capsules Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone Capsules Production (2021-2032) & (K Units)
Figure 5. World Progesterone Capsules Average Price (2021-2032) & (US$/Unit)
Figure 6. World Progesterone Capsules Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone Capsules Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone Capsules Production (2021-2032) & (K Units)
Figure 9. Europe Progesterone Capsules Production (2021-2032) & (K Units)
Figure 10. China Progesterone Capsules Production (2021-2032) & (K Units)
Figure 11. Japan Progesterone Capsules Production (2021-2032) & (K Units)
Figure 12. Progesterone Capsules Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 15. World Progesterone Capsules Consumption Market Share by Region (2021-2032)
Figure 16. United States Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 17. China Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 18. Europe Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 19. Japan Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 20. South Korea Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 22. India Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Progesterone Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Progesterone Capsules Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Progesterone Capsules Markets in 2025
Figure 26. United States VS China: Progesterone Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone Capsules Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Progesterone Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 30. China Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 32. World Progesterone Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Progesterone Capsules Production Value Market Share by Type in 2025
Figure 34. Originator Products
Figure 35. Branded Generics
Figure 36. World Progesterone Capsules Production Market Share by Type (2021-2032)
Figure 37. World Progesterone Capsules Production Value Market Share by Type (2021-2032)
Figure 38. World Progesterone Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Progesterone Capsules Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 40. World Progesterone Capsules Production Value Market Share by Dosage in 2025
Figure 41. 6 Capsules Per Bottle
Figure 42. 12 Capsules Per Bottle
Figure 43. 30 Capsules Per Bottle
Figure 44. Others
Figure 45. World Progesterone Capsules Production Market Share by Dosage (2021-2032)
Figure 46. World Progesterone Capsules Production Value Market Share by Dosage (2021-2032)
Figure 47. World Progesterone Capsules Average Price by Dosage (2021-2032) & (US$/Unit)
Figure 48. World Progesterone Capsules Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 49. World Progesterone Capsules Production Value Market Share by Clinical Indication in 2025
Figure 50. Luteal Phase Support in Assisted Reproductive Technology
Figure 51. Treatment of Luteal Phase Deficiency
Figure 52. Others
Figure 53. World Progesterone Capsules Production Market Share by Clinical Indication (2021-2032)
Figure 54. World Progesterone Capsules Production Value Market Share by Clinical Indication (2021-2032)
Figure 55. World Progesterone Capsules Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 56. World Progesterone Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Progesterone Capsules Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Progesterone Capsules Production Market Share by Application (2021-2032)
Figure 62. World Progesterone Capsules Production Value Market Share by Application (2021-2032)
Figure 63. World Progesterone Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Progesterone Capsules Industry Chain
Figure 65. Progesterone Capsules Procurement Model
Figure 66. Progesterone Capsules Sales Model
Figure 67. Progesterone Capsules Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Progesterone Capsules Picture
Figure 2. World Progesterone Capsules Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone Capsules Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone Capsules Production (2021-2032) & (K Units)
Figure 5. World Progesterone Capsules Average Price (2021-2032) & (US$/Unit)
Figure 6. World Progesterone Capsules Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone Capsules Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone Capsules Production (2021-2032) & (K Units)
Figure 9. Europe Progesterone Capsules Production (2021-2032) & (K Units)
Figure 10. China Progesterone Capsules Production (2021-2032) & (K Units)
Figure 11. Japan Progesterone Capsules Production (2021-2032) & (K Units)
Figure 12. Progesterone Capsules Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 15. World Progesterone Capsules Consumption Market Share by Region (2021-2032)
Figure 16. United States Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 17. China Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 18. Europe Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 19. Japan Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 20. South Korea Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 22. India Progesterone Capsules Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Progesterone Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Progesterone Capsules Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Progesterone Capsules Markets in 2025
Figure 26. United States VS China: Progesterone Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone Capsules Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Progesterone Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 30. China Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Progesterone Capsules Production Market Share 2025
Figure 32. World Progesterone Capsules Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Progesterone Capsules Production Value Market Share by Type in 2025
Figure 34. Originator Products
Figure 35. Branded Generics
Figure 36. World Progesterone Capsules Production Market Share by Type (2021-2032)
Figure 37. World Progesterone Capsules Production Value Market Share by Type (2021-2032)
Figure 38. World Progesterone Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Progesterone Capsules Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 40. World Progesterone Capsules Production Value Market Share by Dosage in 2025
Figure 41. 6 Capsules Per Bottle
Figure 42. 12 Capsules Per Bottle
Figure 43. 30 Capsules Per Bottle
Figure 44. Others
Figure 45. World Progesterone Capsules Production Market Share by Dosage (2021-2032)
Figure 46. World Progesterone Capsules Production Value Market Share by Dosage (2021-2032)
Figure 47. World Progesterone Capsules Average Price by Dosage (2021-2032) & (US$/Unit)
Figure 48. World Progesterone Capsules Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 49. World Progesterone Capsules Production Value Market Share by Clinical Indication in 2025
Figure 50. Luteal Phase Support in Assisted Reproductive Technology
Figure 51. Treatment of Luteal Phase Deficiency
Figure 52. Others
Figure 53. World Progesterone Capsules Production Market Share by Clinical Indication (2021-2032)
Figure 54. World Progesterone Capsules Production Value Market Share by Clinical Indication (2021-2032)
Figure 55. World Progesterone Capsules Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 56. World Progesterone Capsules Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Progesterone Capsules Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Progesterone Capsules Production Market Share by Application (2021-2032)
Figure 62. World Progesterone Capsules Production Value Market Share by Application (2021-2032)
Figure 63. World Progesterone Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Progesterone Capsules Industry Chain
Figure 65. Progesterone Capsules Procurement Model
Figure 66. Progesterone Capsules Sales Model
Figure 67. Progesterone Capsules Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
